Characterization of lectin-mediated brain uptake of HIV-1 GP120.
about
Role of anti-inflammatory compounds in human immunodeficiency virus-1 glycoprotein120-mediated brain inflammation.Transport of human immunodeficiency virus type 1 pseudoviruses across the blood-brain barrier: role of envelope proteins and adsorptive endocytosisBacterial lipoproteins can disseminate from the periphery to inflame the brain.Multifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cellsHuman immunodeficiency virus-1 uses the mannose-6-phosphate receptor to cross the blood-brain barrierRole of the immune system in HIV-associated neuroinflammation and neurocognitive implications.Anti-aβ oligomer IgG and surface sialic acid in intravenous immunoglobulin: measurement and correlation with clinical outcomes in Alzheimer's disease treatment.Sialic acid associated with αvβ3 integrin mediates HIV-1 Tat protein interaction and endothelial cell proangiogenic activation.Lipopolysaccharide-enhanced transcellular transport of HIV-1 across the blood-brain barrier is mediated by the p38 mitogen-activated protein kinase pathwayLigand-based targeted therapy for cancer tissue.Modulators of IgG penetration through the blood-brain barrier: Implications for Alzheimer's disease immunotherapy.Peroxisome proliferator-activated receptor-gamma: potential molecular therapeutic target for HIV-1-associated brain inflammation.Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion.RTB Lectin: a novel receptor-independent delivery system for lysosomal enzyme replacement therapiesAntibody blood-brain barrier efflux is modulated by glycan modification.Drug transport into the central nervous system: using newer findings about the blood-brain barriers.
P2860
Q33713071-F2BFF2D5-899E-49B1-9394-1FA9F3CF151AQ33840847-9D8BC5ED-BC21-4449-97BB-4330B63AA81CQ33882495-45D75036-D8AC-4DD9-A356-6CEFDE0AECD2Q34227784-5F190147-D636-48DC-BCBE-F6E6E7E6877DQ34326270-82BFCD77-BDF6-4F2C-963E-2AAA80BA79ADQ35125996-641DD193-74D7-47B7-9A9B-B24EC83BD90EQ35590968-923C17C4-626D-4E44-8430-E091EBEA5CA9Q36016939-D2CAC46E-AB8B-4169-9A96-CC1FB50B33D9Q36660185-11F6FE15-33A5-48F9-9FC3-02FA6A90D47BQ37425224-FC9EFC1B-A239-40B8-B5CB-27AD358C39DDQ39062945-64E5521B-8A09-4B66-8276-1CCD82D87DDAQ40050469-819F4D48-7184-4B55-9302-28165D10AEA1Q40108800-C7BA0EEE-3671-48F9-B44D-F06D0C0056BDQ41977743-C594EA80-0907-422A-B50A-96B0F29A752DQ46348633-E519BB5F-B50D-4038-9918-2E8732F14C07Q48489678-0D0372E6-E477-4A5D-BA76-22787B132DD1
P2860
Characterization of lectin-mediated brain uptake of HIV-1 GP120.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Characterization of lectin-mediated brain uptake of HIV-1 GP120.
@en
Characterization of lectin-mediated brain uptake of HIV-1 GP120.
@nl
type
label
Characterization of lectin-mediated brain uptake of HIV-1 GP120.
@en
Characterization of lectin-mediated brain uptake of HIV-1 GP120.
@nl
prefLabel
Characterization of lectin-mediated brain uptake of HIV-1 GP120.
@en
Characterization of lectin-mediated brain uptake of HIV-1 GP120.
@nl
P2860
P1476
Characterization of lectin-mediated brain uptake of HIV-1 GP120.
@en
P2860
P304
P356
10.1002/(SICI)1097-4547(19981115)54:4<522::AID-JNR9>3.0.CO;2-O
P577
1998-11-01T00:00:00Z